Training activity information
Details
Present a case study of a patient undergoing treatment or treated with a personalised medicine strategy
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Local and national guidelines and regulations
- Patient management plan
- Comparison of novel treatment and current standard care
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What are the key principles of personalised medicine in the context of advanced therapies and stem cells? What aspects of a personalised medicine approach should the case study highlight?
- What constitutes a personalised medicine strategy in your specialty (e.g., genetic markers guiding treatment decisions)? What specific treatments or approaches fall under this category?
- What clinical and laboratory data are relevant to illustrate the personalised approach in the chosen case? What were the outcomes for the patient treated with this strategy?
- What is the expected format and audience for the presentation?
- Will you review the patient’s relevant clinical, laboratory, and potentially genomic data?
- Will you research the specific personalised medicine strategy used in the case?
- What challenges might you face in understanding the scientific basis or clinical implications of the personalised approach?
- How do you feel about presenting a case that might involve cutting-edge or complex therapeutic strategies?
In action
- As you present the case, how are you explaining the rationale behind the personalised medicine approach and its impact on the patient’s treatment? Are you using clear and accessible language?
- When discussing the specific biomarkers or therapies involved, how are you ensuring the accuracy and clarity of your explanation?
- Are you finding it easier to describe the clinical aspects of the case or the scientific basis of the personalised medicine strategy? What contributes to this?
- What challenges are you facing (e.g., explaining complex molecular mechanisms, addressing questions about the evidence base)? How are you responding in the moment?
- What are you learning about communicating the principles and practice of personalised medicine to different audiences?
- If you are asked about aspects of personalised medicine that are outside your current knowledge, are you considering how to respond honestly and appropriately?
On action
- Summarise the key aspects of the personalised medicine case you presented, including the patient’s specific characteristics (e.g., genetic markers), the tailored treatment strategy employed, and the outcomes achieved.
- How did you explain the concept of personalised medicine in this context?
- What did you learn about the principles of personalised medicine and how specific biomarkers or patient profiles can guide treatment decisions?
- What challenges did you encounter in explaining the scientific basis of the personalised approach?
- Were there any unexpected questions or discussions related to the ethical or practical implications of personalised medicine? How did you address these in the moment?
- Thinking about how you structured your presentation, how did your real-time decisions about which information to emphasise impact the audience’s understanding of the benefits and complexities of personalised medicine?
- How important are clear communication skills for effectively conveying the principles and potential of personalised medicine strategies in clinical practice?
- What specific examples or applications of personalised medicine in haematology do you want to explore further?
- How will this experience influence your approach to explaining complex scientific concepts to different audiences, particularly in the context of personalised medicine?
- What are your next steps in terms of seeking feedback on your presentation or researching further into the field of personalised medicine?
- Do you need any further resources or training on the scientific basis, clinical applications, or ethical considerations of personalised medicine?
Beyond action
- Have you prepared or presented other case studies focusing on personalised medicine strategies within the realm of advanced therapies since this training activity? How did your understanding of the laboratory’s role in these strategies evolve?
- Have you reviewed your initial reflect-on-action notes from this presentation? What aspects of showcasing the impact of personalised medicine do you now view differently in the context of haematological disorders?
- Can you recall discussions or situations where your knowledge of personalised treatment protocols was relevant?
- Have you engaged in professional storytelling with peers or colleagues about successful or challenging cases involving personalised medicine? Did this change your perspective?
- Has this training activity improved your ability to integrate complex genomic or molecular data with clinical information in the context of personalised medicine?
- Do you feel more confident in communicating the laboratory contributions to personalised treatment strategies to other healthcare professionals?
- Has preparing this case study enhanced your understanding of the potential benefits and challenges of implementing personalised medicine in routine clinical practice for haematological conditions?
- Have the skills in data integration, critical analysis, and communication developed through this activity been transferable to other areas of your professional practice?
- How will your experience in preparing and presenting case studies on personalised medicine be valuable in future educational or professional settings, especially as this field continues to advance within advanced therapies?
- Will your understanding of the laboratory’s crucial role in personalised medicine contribute to your ability to support its further implementation and development?
- How might this experience inform your future development in areas such as molecular diagnostics, bioinformatics, or clinical genomics related to haematological disorders?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Practice in accordance with legislation regarding use of human tissue. |
| # 3 |
Outcome
Appraise the application of novel and evolving therapies in the treatment of haematological conditions. |